^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

irinotecan liposomal

Associations
Company:
CSPC Pharma
Drug class:
Topoisomerase I inhibitor
Related drugs:
Associations
23d
New trial
|
irinotecan liposomal
2ms
New trial
|
5-fluorouracil • leucovorin calcium • irinotecan liposomal
3ms
New P1 trial • Metastases
|
UGT1A1*1*1
|
Avastin (bevacizumab) • Erbitux (cetuximab) • 5-fluorouracil • irinotecan liposomal
over2years
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer (clinicaltrials.gov)
P2, N=66, Not yet recruiting, CSPC Ouyi Pharmaceutical Co., Ltd. | Trial completion date: Aug 2021 --> Aug 2024 | Trial primary completion date: Aug 2021 --> Aug 2023
Clinical • Trial completion date • Trial primary completion date
|
UGT1A1 (UDP glucuronosyltransferase family 1 member A1)
|
UGT1A1*1*1
|
5-fluorouracil • leucovorin calcium • Enshuxing (enlonstobart) • irinotecan liposomal
over2years
Clinical • New P2 trial
|
UGT1A1 (UDP glucuronosyltransferase family 1 member A1)
|
UGT1A1*1*1
|
gemcitabine • 5-fluorouracil • albumin-bound paclitaxel • oxaliplatin • leucovorin calcium • irinotecan liposomal
over2years
Clinical • New P2 trial
|
UGT1A1 (UDP glucuronosyltransferase family 1 member A1)
|
UGT1A1*1*1
|
5-fluorouracil • leucovorin calcium • Enshuxing (enlonstobart) • irinotecan liposomal